MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

39.20 -0.82 (-2.05%)
Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
News headline image
Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.9% in the morning session after investors looked past a recent insider stock sale and focused on the company's strong growth... 
Via StockStory
News headline image
Benzinga Bulls And Bears: Stellantis, Papa John's, Oklo — And Trade Tensions Shake Chip Stocks ↗
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Topics World Trade
News headline image
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet ↗
Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure. 
Via Benzinga
Topics ETFs Government
Hims & Hers Health Brings Menopause, Perimenopause Treatments On Its Platform ↗
Via Stocktwits
News headline image
Why Is Hims & Hers Health Stock Down 12% Today? ↗
According to a SEC filing on Thursday, CEO Andrew Dudum sold 175,661 shares of the company for an aggregate value of about $11 million. 
Via Stocktwits
Topics Regulatory Compliance
News headline image
Why Hims & Hers Health Shares Are Sliding Friday ↗
Shares of Hims & Hers Health are trading lower Friday morning after comments from President Donald Trump indicated that he expects the prices of popular weight-loss drugs to decrease. 
Via Benzinga
Topics Government
News headline image
Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs' ↗
Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-loss drugs are going to go down in price. 
Via Benzinga
Topics Government
News headline image
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.8% in the afternoon session after a Bank of America analyst maintained a Sell rating on the stock, citing multiple concerns about the... 
Via StockStory
News headline image
Hims & Hers Stock's 150% Surge Is All Fundamentals—No Novo, No Problem ↗
Hims & Hers (HIMS) has seen surprising success, up 150% YTD, driven by their new menopause specialty and refocusing on healthcare. 
Via Benzinga
News headline image
Hims & Hers Stock Jumps 9% After Huge Announcement ↗
New products are coming to the Hers platform. 
Via The Motley Fool
News headline image
Hims & Hers Stock Notches Best Day In 3 Months After BofA’s Bullish Call On Menopause Launch: Retail Hails Year’s ‘Best Swing Trade Stock’ ↗
The rally followed BofA Securities’ announcement that the new menopause and perimenopause service represents a multi-billion-dollar market opportunity for HIMS, supporting revenue diversification. 
Via Stocktwits
News headline image
Hims & Hers, Salesforce, Omeros, United Airlines, And Sea Ltd: Why These 5 Stocks Are On Investors' Radars Today ↗
Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31. 
Via Benzinga
Topics Stocks
News headline image
Why Hims & Hers Stock Blasted 16% Higher on Wednesday ↗
Investors liked what they heard about the company's latest expansion of its business. 
Via The Motley Fool
News headline image
Investors Are Buying Hims & Hers Health Stock Following Wednesday's Platform Expansion Announcement ↗
Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Wednesday following the company's launch of a new menopause and perimenopause care specialty on its Hers platform. 
Via Benzinga
News headline image
Why Are Hims & Hers Health (HIMS) Shares Soaring Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 5.7% in the afternoon session after the company announced the launch of perimenopause and menopause treatment options on its platform.... 
Via StockStory
Topics Artificial Intelligence
News headline image
IBD 50's Hims & Hers Surges After Announcing A Menopause Care Launch ↗
Shares are nearing a buy point out of a cup-with-handle base. 
Via Investor's Business Daily
News headline image
Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026
From Hims & Hers
Via Business Wire
News headline image
Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock? ↗
Investors looking at the healthcare industry have two excellent choices with UnitedHealth and Hims & Hers. 
Via The Motley Fool
News headline image
Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025
From Hims & Hers
Via Business Wire
News headline image
HIMS & Hers Health Inc (NYSE:HIMS): A High-Growth Telehealth Stock Poised for a Breakout ↗
Discover how Hims & Hers Health (HIMS) combines explosive revenue growth with a bullish technical setup, making it a top telehealth stock to watch. 
Via Chartmill
News headline image
Why Hims & Hers Health (HIMS) Stock Is Nosediving
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.5% in the afternoon session after a Bank of America report highlighted weakening order trends and a lowered fourth-quarter revenue... 
Via StockStory
Topics World Trade
News headline image
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office
From Hims & Hers
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
HIMS & HERS HEALTH INC (NYSE:HIMS) Shows Strong Technical Setup Ahead of Potential Breakout ↗
HIMS stock shows strong technical momentum and a consolidation pattern, suggesting a potential breakout. The setup offers a clear risk/reward profile for technical traders. 
Via Chartmill
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Why Hims & Hers Stock Slipped Today ↗
Investors generally aren't fond of C-suite changes in relatively young businesses. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
HIMS & HERS HEALTH INC (NYSE:HIMS) Shows High-Growth Momentum and Technical Breakout Potential ↗
Hims & Hers (HIMS) is a high-growth momentum stock with strong earnings and a positive technical breakout setup, offering a compelling opportunity for investors. 
Via Chartmill
News headline image
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics World Trade
News headline image
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story